Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1

BACKGROUND: Treatment with Bacillus Calmette-Guérin (BCG) is the gold standard adjuvant immunotherapy of non-muscle invasive bladder cancer (NMIBC), although it fails in one third of the patients. NMIBC expresses two tumor-associated O-linked carbohydrates: the disaccharide (Galβ1,3GalNAc) Thomsen-F...

Descripción completa

Detalles Bibliográficos
Autores principales: Severino, Paulo F., Silva, Mariana, Carrascal, Mylene, Malagolini, Nadia, Chiricolo, Mariella, Venturi, Giulia, Barbaro Forleo, Roberto, Astolfi, Annalisa, Catera, Mariangela, Videira, Paula A., Dall’Olio, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816560/
https://www.ncbi.nlm.nih.gov/pubmed/29454317
http://dx.doi.org/10.1186/s12885-018-4107-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816560/
https://www.ncbi.nlm.nih.gov/pubmed/29454317
http://dx.doi.org/10.1186/s12885-018-4107-1

Ejemplares similares